Intervention Study on Weight Loss in Patients With Obesity

Condition(s) studied

Investigational drug(s) / intervention(s)

Socratic Questioning Method: Socratic questioning is a method in which behaviour is examined through questions such as "what, where, which, who, when, how, and why". It consists of four stages: defining the problem, evaluating and identifying alternatives, redefining, and discussing feasible outcomes. Through this process, individuals develop their critical thinking skills and make self-evaluations.

Study summary

The goal of this clinical trial is to evaluate the feasibility of using Socratic questioning as an alternative method for weight loss in adult patients with obesity (aged 18 to 65) in a primary care setting.

The main question it aims to answer is:

-Is Socratic questioning an effective alternative approach for promoting weight loss in patients with obesity?

Researchers will compare participants receiving Socratic questioning during follow-up visits with those receiving regular care to see if the intervention leads to greater weight loss.

Participants will:

* Complete a baseline questionnaire including 9 demographic questions and the 14-item Hospital Anxiety and Depression Scale (approx. 5 minutes).
* Attend five in-person follow-up visits with their family physician over a 3-month period (every 15 or 30 days), where they will receive brief counseling (10-15 minutes per visit) and have their weight, height, and waist circumference measured.
* Complete a 17-question final questionnaire at the end of 3 months (approx. 10-15 minutes).
* Be referred to mental health services if necessary, based on initial screening results.

Eligibility

Primary outcome measure(s)

• Change from Baseline in Body Weight at 3 Months — Baseline and 3 months
  Body weight will be measured in kilograms using a calibrated digital scale. The outcome is the difference in percent change in body weight from baseline to 3 months between the Socratic questioning intervention group and the regular care control group.

Trial sites (1)

Other trials for the same condition